The Governing Council of the University of Toronto;The University Court Of The University Of Aberdeen
发明人:
申请号：
EP15836620.3
公开号：
EP3186225A4
申请日:
2015.08.26
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present disclosure relates to indole derivatives of the formula (I) which are cannabinoid type 1 receptor modulators and which are useful in the treatment of diseases in which modulation of the receptor is beneficial； to processes for their preparation； to pharmaceutical compositions comprising them； and to methods of using them.
